Global & Public Health (all articles)
Observational analysis in Lombardy, Italy, showed a gradual decrease in protection against SARS-CoV-2 clinical outcomes after the second dose of vaccine.
30 Jan, 2022 | 14:51h | UTCCommentary: COVID-19 vaccine: what are we doing and what should we do? – The Lancet Infectious Diseases
Despite the ongoing spread of Omicron, some European countries have decided to lift Covid-19 restrictions.
30 Jan, 2022 | 14:37h | UTCEngland lifts COVID restrictions as omicron threat recedes – Associated Press
Denmark confirms plan to lift Covid-19 restrictions on February 1st – The Local dk
Netherlands lifts toughest Covid curbs with Denmark and France set to follow – The Guardian
Commentary on Twitter
IMMUNITY: Yes, UK dropped all COVID restrictions along with many countries in Europe following suit (masks optional, no vaccine passports, no asymptomatic testing) but that is due to high vax rates + Omicron infused immunity + advances in therapeuticshttps://t.co/fsbPkUqwSr
— Monica Gandhi MD, MPH (@MonicaGandhi9) January 28, 2022
Perspective | Where do we stand with Omicron? The data, the math, the patterns, and the exit.
28 Jan, 2022 | 08:39h | UTCWhere do we stand with Omicron? – by Dr. Eric Topol
Commentary on Twitter
Where do we stand with Omicron?
I've summarized the new data, math, patterns, and potential exit ramphttps://t.co/SyCmCzkBQX @SubstackInc— Eric Topol (@EricTopol) January 22, 2022
After Omicron, some scientists foresee ‘a period of quiet’.
28 Jan, 2022 | 08:36h | UTCAfter Omicron, some scientists foresee ‘a period of quiet’ – Science
RCT: Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination.
28 Jan, 2022 | 08:37h | UTCRelated:
WHO issues interim recommendations for heterologous COVID-19 vaccine schedules.
A second version of omicron is spreading. Here’s why scientists are on alert.
28 Jan, 2022 | 08:32h | UTCA second version of omicron is spreading. Here’s why scientists are on alert – NPR
See also: Scientists Watch, Worry About New ‘Stealth’ Version of Omicron Variant – HealthDay
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life.
28 Jan, 2022 | 08:30h | UTC
Perspective: Will Omicron leave most of us immune?
28 Jan, 2022 | 08:34h | UTCWill Omicron Leave Most of Us Immune? – The Atlantic
They built a smarter approach to Covid clinical trials. Now they want to do the same for other diseases.
28 Jan, 2022 | 08:31h | UTC
Casualties of COVID: Insulin and Dialysis – “How the pandemic has been life-threatening to people living with diabetes and chronic kidney disease”.
28 Jan, 2022 | 08:28h | UTCCasualties of COVID: Insulin and Dialysis - Think Global Health
During the COVID-19 pandemic, female, primary care, and behavioral health physicians were most likely to be early adopters of virtual health care. Physicians born between 1928 and 1945 and in surgical specialties were less likely to be early adopters.
28 Jan, 2022 | 08:20h | UTC
Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
27 Jan, 2022 | 10:03h | UTC
Commentary on Twitter
Investigators assessed the in vitro activities of seven monoclonal antibodies & three antiviral drugs against #COVID19 variants. All antibodies showed no or weak neutralizing activity against omicron; two drugs effective at omicron neutralization. https://t.co/rOZzmtsDZS pic.twitter.com/shfKDW6r5q
— NEJM (@NEJM) January 26, 2022
Opinion: Despite Omicron arriving, keeping schools open as safely as possible should be the goal.
27 Jan, 2022 | 09:58h | UTC
Omicron’s most crucial warning: A disease can move much faster than we can.
27 Jan, 2022 | 09:57h | UTCOmicron’s most crucial warning: A disease can move much faster than we can – Vox
[Preprint] SARS-CoV-2 Omicron transmission in Danish households.
27 Jan, 2022 | 09:53h | UTCSARS-CoV-2 Omicron VOC Transmission in Danish Households – medRxiv
News Release: Danish researchers investigate Omicron transmission in Danish households – Statens Serum Institut
Commentary on Twitter
Reminder that, despite its infectivity, Omicron's household attack rate is ~1-in-3 (less in fully vaxxed). People often assume that, if one person in household is infected, it's inevitable everybody'll get it. Ain't so; worth trying to isolate if feasible.https://t.co/OLcUtfH8Up
— Bob Wachter (@Bob_Wachter) January 23, 2022
Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study.
27 Jan, 2022 | 09:46h | UTCNews Release: How has the COVID-19 pandemic impacted clinicians who care for children with cancer? – Wiley
Italian lab study finds Sputnik V beat Pfizer’s mRNA vaccine against Omicron – yielding higher antibody levels.
27 Jan, 2022 | 09:47h | UTC
RCT: Heterologous (Pfizer, J&J, or AstraZeneca) vs. homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil.
26 Jan, 2022 | 02:30h | UTCCommentaries:
Boosting immunity after CoronaVac – The Lancet
Covid-19: CoronaVac immunity is strongest after boosting with a different vaccine – The BMJ
Commentary on Twitter
Heterologous boosting after 2 doses of #CoronaVac COVID-19 vaccine results in more robust immune responses than homologous boosting, study suggests. https://t.co/845JFnn3t7 pic.twitter.com/ibT3b5rs2K
— The Lancet (@TheLancet) January 23, 2022
As Pfizer and BioNTech begin a clinical trial of Omicron-based vaccine, the timeline to authorization is unclear.
26 Jan, 2022 | 02:20h | UTCSee also:
Pfizer begins testing omicron-matched COVID shots in adults – Associated Press
Pfizer and BioNTech start trials of new Omicron-specific jab – BBC
Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine – NPR
Cohort study: Among patients who survived ICU treatment for COVID-19, 75% still reported physical, mental, or cognitive symptoms after 1 year.
26 Jan, 2022 | 02:28h | UTCCommentaries:
75% of COVID ICU survivors have physical symptoms 1 year on – CIDRAP
Majority of COVID-19 survivors experience health problems one-year post ICU admission – News Medical
Opinion: Preventing SARS-CoV-2 transmission in health care settings in the context of the Omicron variant.
26 Jan, 2022 | 02:14h | UTC
Commentary on Twitter
Our new piece in @JAMA_current
Transmission of #SARSCoV2 in healthcare settings is a serious concern
We outline three ways hospitals can better prepare for surges— mandating boosters, increasing frequency of testing, & upgrading to N95 maskshttps://t.co/2xRKdKPlhO pic.twitter.com/y0L4UzUNSo
— Abraar Karan (@AbraarKaran) January 24, 2022
RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment.
26 Jan, 2022 | 01:58h | UTC
Commentary on Twitter
In this 2-year study, data showed that electronic directly observed therapy (eDOT) was as effective as traditional in-person DOT for ensuring high adherence to treatment of tuberculosis disease. @CDC_TB @nycHealthy @ColumbiaMed https://t.co/yTrU1JRuwn pic.twitter.com/QXthE4d266
— JAMA Network Open (@JAMANetworkOpen) January 20, 2022
ACP living, rapid review: risk for reinfection after SARS-CoV-2.
25 Jan, 2022 | 09:47h | UTC
Commentary on Twitter
Risk for Reinfection After #SARSCoV2: previous infection reduced risk for reinfection by 87% (95% CI, 84% to 90%). Protection remained above 80% for at least 7 months, but no study followed patients after the emergence of the Delta or #Omicron variant. https://t.co/eruEf1w8Vo
— Prof. Nick Talley (@Prof_NickTalley) January 25, 2022
WHO drops opposition to boosters – recommends third Pfizer jab for adults & two vaccines for children ages 5 & up.
25 Jan, 2022 | 09:45h | UTCRelated:
WHO updated roadmap for prioritizing uses of COVID-19 vaccines.
WHO advisers weigh in on COVID-19 boosters, Pfizer vaccine in younger kids.
A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.
25 Jan, 2022 | 09:43h | UTCNews release: BNT162b2 COVID-19 vaccine associated with increased risk of carditis – American College of Physicians
Related:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.